​

XTL Biopharmaceuticals Ownership | Who Owns XTL Biopharmaceuticals?

OverviewChart

XTL Biopharmaceuticals Ownership Summary

XTL Biopharmaceuticals is owned by 1.80% institutional investors, 21.44% insiders, and 76.76% retail investors. Tower research capital llc (trc) is the largest institutional shareholder, holding 0% of XTLB shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in XTL Biopharmaceuticals shares.

XTLB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockXTL Biopharmaceuticals1.80%21.44%76.76%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tower research capital llc (trc)---
Noked israel---
Gamma investing---
Rhumbline advisers---
Bnp paribas arbitrage, snc---
Ubs group---
Citadel advisors---
Xtx topco---
Morgan stanley---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tower research capital llc (trc)---
Noked israel---
Gamma investing---
Rhumbline advisers---
Bnp paribas arbitrage, snc---
Ubs group---
Citadel advisors---
Xtx topco---
Morgan stanley---

Top Buyers

HolderShares% AssetsChange
Morgan stanley---10.00
Tower research capital llc (trc)---244.00
Bnp paribas arbitrage, snc---300.00
Ubs group---763.00
Xtx topco---10.24K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---75.87K
Noked israel---49.72K
Rhumbline advisers---30.11K
Gamma investing---12.89K
Xtx topco---10.24K

Sold Out

HolderChange
Morgan stanley-10.00
Tower research capital llc (trc)-244.00
Bnp paribas arbitrage, snc-300.00
Ubs group-763.00
Xtx topco-10.24K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20263-50.00%7,566-89.59%10.60%2-1-75.00%
Mar 31, 20266-72,702-77.95%6918.00%2-50.00%4300.00%
Dec 31, 20254-243,6237.36%14127.37%2100.00%1-
Sep 30, 2025433.33%226,9234.34%3323032.82%1-50.00%1-
Jun 30, 20254-228,496-7.98%-1633.99%2100.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index1.44K0.06%-786.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 18, 2008EDELMAN JOSEPH-Sell$412.02K
Nov 19, 2008EDELMAN JOSEPH-Sell$1.47M
Nov 18, 2008EDELMAN JOSEPH-Sell$4.73K
Nov 18, 2008EDELMAN JOSEPH-Sell$64.56K
Nov 18, 2008EDELMAN JOSEPH-Sell$3.48M

Insider Transactions Trends

DateBuySell
2008 Q4-8
2008 Q3--
2008 Q228-
2008 Q1143-
2007 Q46-

XTLB Ownership FAQ

Who Owns XTL Biopharmaceuticals?

XTL Biopharmaceuticals shareholders are primarily institutional investors at 1.80%, followed by 21.44% insiders and 76.76% retail investors. The average institutional ownership in XTL Biopharmaceuticals's industry, Biotech Stocks , is 379.61%, which XTL Biopharmaceuticals falls below.

Who owns the most shares of XTL Biopharmaceuticals?

XTL Biopharmaceuticals’s largest shareholders are Tower research capital llc (trc) (0 shares, 0%), Noked israel (0 shares, 0%), and Gamma investing (0 shares, 0%). Together, they hold 0% of XTL Biopharmaceuticals’s total shares outstanding.

Does Blackrock own XTL Biopharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of XTL Biopharmaceuticals.

Who is XTL Biopharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is XTL Biopharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 XTL Biopharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of XTL Biopharmaceuticals shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of XTL Biopharmaceuticals shares, with 0.06% of its total shares outstanding invested in 1.44K XTL Biopharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools